Huberman Lab

Podbit · Huberman Lab

Essentials: Tools for Hormone Optimization in Males | Dr. Kyle Gillett

Explore episode Jul 2, 2026
Health & Fitness
Hair Loss Drugs: The Topical vs. Systemic Trade-off

Essentials: Tools for Hormone Optimization in Males | Dr. K… · Jul 2, 2026 Health & Fitness

Topical caffeine and ketoconazole weakly block androgens at the scalp without systemic absorption. Topical finasteride still lowers systemic DHT by about 30%. But topical dutasteride, with its rapid local half-life, doesn't affect systemic DHT at all — making it the cleanest option for protecting hair without hormonal side effects.

Where this was said

Hair Loss, Caffeine, Finasteride, Dutasteride

At 39:02 · chapter starts 38:10

The final content segment addresses the most common male vanity concern: hair loss. Huberman asks whether systemic DHT blockers like Propecia cause the libido and motivation side effects their reputation suggests. Gillett pivots to topical alternatives. Topical caffeine can weakly crowd out androgens at the scalp follicle — effective enough to be clinically significant but mild enough to need combination with ketoconazole, another weak topical anti-androgen. A critical warning: topical spironolactone should not be used by males because its molecular size means it absorbs systemically. Topical finasteride also has systemic absorption, lowering systemic DHT by about 30% — meaningful but moderate. The standout option is topical dutasteride: its rapid half-life at lower topical doses means it acts locally without reaching systemic circulation at all, protecting hair without measurably affecting systemic DHT. Gillett notes he has seen this confirmed anecdotally in many patients on topical dutasteride therapy.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.